Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder

PURPOSE: We sought to better understand how dose and titration with duloxetine treatment may impact tolerability and treatment discontinuation in patients with major depressive disorder. PATIENTS AND METHODS: We investigated Phase III duloxetine trials. Group 1 was a single placebo-controlled study...

Descripción completa

Detalles Bibliográficos
Autores principales: Harada, Eiji, Shirakawa, Osamu, Satoi, Yoichi, Marangell, Lauren B, Escobar, Rodrigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714731/
https://www.ncbi.nlm.nih.gov/pubmed/26811681
http://dx.doi.org/10.2147/NDT.S86598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714731/
https://www.ncbi.nlm.nih.gov/pubmed/26811681
http://dx.doi.org/10.2147/NDT.S86598

Ejemplares similares